Digestion of rhizocticins to (Z)-L-2-amino-5-phosphono-3-pentenoic acid: revision of the absolute configuration of plumbemycins A and B.
Fredenhagen
A
A
Pharmaceutical Research Department, Core Drug Discovery Technologies, Basel, Switzerland.
Angst
C
C
Peter
H H
HH
D015763:2-Amino-5-phosphonovalerate / Q000031:analogs & derivatives* / Q000737:chemistry; D000596:Amino Acids / Q000737:chemistry / Q000302:isolation & purification; D000935:Antifungal Agents / Q000737:chemistry* / Q000302:isolation & purification; D001412:Bacillus subtilis; D008968:Molecular Conformation; D009842:Oligopeptides / Q000737:chemistry* / Q000302:isolation & purification; D009943:Organophosphorus Compounds / Q000737:chemistry* / Q000302:isolation & purification; D013237:Stereoisomerism; D013302:Streptomyces; D013912:Threonine / Q000037:antagonists & inhibitors
D000596:Amino Acids; D000935:Antifungal Agents; D009842:Oligopeptides; D009943:Organophosphorus Compounds; C096640:rhizocticin B; C063847:rhizocticin A; C096637:2-amino-5-phosphono-3-pentenoic acid; D013912:Threonine; C096639:plumbemycin B; C096638:plumbemycin A; D015763:2-Amino-5-phosphonovalerate